BMY
35
2
AXP
74
-3
DO
58
6
ZTS
38
9
AIZ
66
-2
HST
49
-3
APH
73
2
VTR
78
2
PAYX
47
-7
HIG
70
-6
NEM
61
-2
CTAS
55
2
HES
79
2
WEC
29
-5
EW
38
-4
MSFT
60
5
ETR
58
-2
FCX
56
2
ABBV
40
-8
ADT
28
3
BMY
35
2
AXP
74
-3
DO
58
6
ZTS
38
9
AIZ
66
-2
HST
49
-3
APH
73
2
VTR
78
2
PAYX
47
-7
HIG
70
-6
NEM
61
-2
CTAS
55
2
HES
79
2
WEC
29
-5
EW
38
-4
MSFT
60
5
ETR
58
-2
FCX
56
2
ABBV
40
-8
ADT
28
3
Financhill
Back

BlueScope Steel 10K Form

Buy
62

BLSFY
BlueScope Steel

Last Price:
74.52
Seasonality Move:
-1.86%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BLSFY News And Ratings

See the #1 stock for the next 7 days that we like better than BLSFY

BLSFY Financial Statistics

Sales & Book Value

Annual Sales: $12.23B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $79.77
Price / Book: 0.93

Profitability

EPS (TTM): 6.09360
Net Income (TTM): $560.07M
Gross Margin: $4.46B
Return on Equity: 7.54%
Return on Assets: 5.29%

BlueScope Steel Earnings Forecast

Key BlueScope Steel Financial Ratios

  • The Gross Profit Margin over the past 23 years for BLSFY is 36.44%.
  • The Selling, General & Administrative Expenses for BLSFY have been equal to 17.33% of Gross Profit Margin.
  • The Research & Development expenses have been 0.20% of Revenue.
  • The Interest Expense is 7.17% of Operating Income.
  • The Net Earning history of BLSFY is 5.55% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 14 years.

BlueScope Steel Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Metals & Mining
Sector: Materials
Current Symbol: BLSFY
Website: bluescope.com

Debt

Debt-to-Equity Ratio: 0.07
Current Ratio: 2.12
Quick Ratio: 0.96

Price-to-Earnings

Trailing P/E Ratio: 10.27
Forward P/E Ratio: 0

BLSFY Technical Analysis vs Fundamental Analysis

Buy
62
BlueScope Steel (BLSFY) is a Buy

Is BlueScope Steel a Buy or a Sell?

  • BlueScope Steel stock is rated a Buy
    The current BlueScope Steel [BLSFY] share price is $74.52. The Score for BLSFY is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.